Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad?

被引：0
|
作者：
Alexopoulos, Dimitrios [1 ]
机构：
[1] Patras Univ Hosp, Dept Cardiol, Patras 26500, Greece
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2013年 / 167卷 / 01期
关键词：
Clopidogrel; Prasugrel; Ticagrelor; Acute coronary syndrome; Percutaneous coronary intervention; Reloading; CHRONIC CLOPIDOGREL THERAPY; PERCUTANEOUS CORONARY INTERVENTION; ANTIPLATELET THERAPY; PLATELET INHIBITION; ANGIOPLASTY; TICAGRELOR; PRASUGREL;
D O I：
10.1016/j.ijcard.2012.09.202
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：292 / 293
页数：2
相关论文
共 50 条
  • [21] Responsiveness to P2Y12 receptor inhibitors
    Esposito, Giovanni
    CURRENT OPINION IN CARDIOLOGY, 2011, 26 : S31 - S37
  • [22] Inflammatory state does not affect the antiplatelet efficacy of potent P2Y12 inhibitors in ACS
    Biesinger, Benedikt S.
    Gasecka, Aleksandra
    Perkmann, Thomas
    Wojta, Johann
    Lesiak, Maciej
    Grygier, Marek
    Eyileten, Ceren
    Postula, Marek
    Filipiak, Krzysztof J.
    Toma, Aurel
    Hengstenberg, Christian
    Siller-Matula, Jolanta M.
    PLATELETS, 2021, 32 (04) : 498 - 506
  • [23] Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI
    Cao, Davide
    Swain, Julie A.
    Sartori, Samantha
    Nardin, Matteo
    Zhang, Zhongjie
    Roumeliotis, Anastasios
    Nicolas, Johny
    Chiarito, Mauro
    Chandiramani, Rishi
    Pivato, Carlo A.
    Spirito, Alessandro
    Giustino, Gennaro
    Stefanini, Giulio G.
    Dangas, George D.
    Baber, Usman
    Bhatt, Deepak L.
    Adams, David H.
    Sharma, Samin K.
    Kini, Annapoorna S.
    Mehran, Roxana
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (08) : 796 - 805
  • [24] Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI
    Capodanno, Davide
    Angiolillo, Dominick J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (01) : 1 - 18
  • [25] Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
    Yang Sun
    Chenze Li
    Lina Zhang
    Dong Hu
    Xudong Zhang
    Ting Yu
    Min Tao
    Dao Wen Wang
    Xiaoqing Shen
    Frontiers of Medicine, 2017, 11 : 53 - 61
  • [26] Poor adherence to P2Y12 antagonists increased cardiovascular risks in Chinese PCI-treated patients
    Sun, Yang
    Li, Chenze
    Zhang, Lina
    Hu, Dong
    Zhang, Xudong
    Yu, Ting
    Tao, Min
    Wang, Dao Wen
    Shen, Xiaoqing
    FRONTIERS OF MEDICINE, 2017, 11 (01) : 53 - 61
  • [27] Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI
    Ali Ayoub
    Karnika Ayinapudi
    Ahmed Al-Ogaili
    Muhammad Siyab Panhwar
    Wael Dakkak
    Thierry LeJemtel
    American Journal of Cardiovascular Drugs, 2021, 21 : 153 - 163
  • [28] Efficacy and Safety of Potent Oral P2Y12 Inhibitors in Medically Managed ACS Patients: a Meta-analysis
    Ma, Sicong
    Li, Zhiguo
    Yu, Peng
    Song, Haixu
    Jiang, Zaixin
    Li, Yi
    Han, Yaling
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 199 - 208
  • [29] Efficacy and Safety of Potent Oral P2Y12 Inhibitors in Medically Managed ACS Patients: a Meta-analysis
    Sicong Ma
    Zhiguo Li
    Peng Yu
    Haixu Song
    Zaixin Jiang
    Yi Li
    Yaling Han
    Cardiovascular Drugs and Therapy, 2020, 34 : 199 - 208
  • [30] Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors
    Girotra, Saket
    Stebbins, Amanda
    Wruck, Lisa
    Marquis-Gravel, Guillaume
    Gupta, Kamal
    Farrehi, Peter
    Benziger, Catherine P.
    Effron, Mark B.
    Whittle, Jeffrey
    Munoz, Daniel
    Kripalani, Sunil
    Anderson, David
    Jain, Sandeep K.
    Polonsky, Tamar S.
    Ahmad, Faraz S.
    Roe, Matthew T.
    Rothman, Russell L.
    Harrington, Robert A.
    Hernandez, Adrian F.
    Jones, W. Schuyler
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2023, 12 (20):
12345